These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11364930)

  • 1. Abacavir for children and adults.
    Treat Rev; 1997 Nov; (No 26-27):10-1. PubMed ID: 11364930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaxo opens broad expanded access program for abacavir (Ziagen).
    Baker R
    BETA; 1998 Apr; ():6. PubMed ID: 11365271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abacavir at last.
    Gilden D
    GMHC Treat Issues; 1998 Mar; 12(3):9. PubMed ID: 11365394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1592U89 (abacavir) compassionate use.
    Treat Rev; 1997 Aug; (No 25):6. PubMed ID: 11364618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abacavir update.
    Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fuss over 1592.
    Vazquez E
    Posit Aware; 1997; 8(5):26-7. PubMed ID: 11364637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abacavir expanded access widened.
    Highleyman L
    BETA; 1998 Jan; ():4. PubMed ID: 11364976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
    Kessler HA; Johnson J; Follansbee S; Sension MG; Mildvan D; Sepulveda GE; Bellos NC; Hetherington SV
    Clin Infect Dis; 2002 Feb; 34(4):535-42. PubMed ID: 11797183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1592 compassionate use program.
    Highleyman L
    BETA; 1997 Sep; ():3. PubMed ID: 11364697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziagen (abacavir) approved: caution essential.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1592 (abacavir, or new name Ziagen) more widely available March 23.
    AIDS Treat News; 1998 Mar; (No 291):6-7. PubMed ID: 11365246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abacavir for salvage or intensification.
    Torres G
    GMHC Treat Issues; 1999 Jan; 13(1):4-5. PubMed ID: 11366111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next HIV guidelines likely to include salvage therapy.
    AIDS Alert; 1999 Jul; 14(7):76-8. PubMed ID: 11366417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1592: protests on small access program.
    AIDS Treat News; 1997 Jun; (No 273):6-8. PubMed ID: 11364401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three drugs now in expanded access.
    Gilden D
    GMHC Treat Issues; 1997 Oct; 11(10):12. PubMed ID: 11364820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abacavir sulfate (Ziagen).
    Simmons P
    Res Initiat Treat Action; 1999 Apr; 5(2):8-10. PubMed ID: 11366289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir's trials and tribulations.
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):1-3. PubMed ID: 11365905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
    Cabrera C; Cozzi-Lepri A; Phillips AN; Loveday C; Kirk O; Ait-Khaled M; Reiss P; Kjaer J; Ledergerber B; Lundgren JD; Clotet B; Ruiz L;
    Antivir Ther; 2004 Oct; 9(5):787-800. PubMed ID: 15535417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.
    van Praag RM; van Heeswijk RP; Jurriaans S; Lange JM; Hoetelmans RM; Prins JM
    Clin Infect Dis; 2001 Oct; 33(8):e91-2. PubMed ID: 11565093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.
    Rozenbaum W; Katlama C; Massip P; Bentata M; Zucman D; Delfraissy JF; Trepo C; David F; Lanier ER; Vavro C; Mamet JP
    Antivir Ther; 2001 Jun; 6(2):135-42. PubMed ID: 11491418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.